Literature DB >> 34234266

The return of individual genomic results to research participants: design and pilot study of Tohoku Medical Megabank Project.

Hiroshi Kawame1, Akimune Fukushima2, Nobuo Fuse3, Fuji Nagami3, Yoichi Suzuki3, Mika Sakurai-Yageta3, Jun Yasuda3, Yumi Yamaguchi-Kabata3, Kengo Kinoshita3, Soichi Ogishima3, Takako Takai3, Shinichi Kuriyama3, Atsushi Hozawa3, Naoki Nakaya3, Tomohiro Nakamura3, Naoko Minegishi3, Junichi Sugawara3, Kichiya Suzuki3, Hiroaki Tomita3, Akira Uruno3, Tomoko Kobayashi3, Yayoi Aizawa3, Tomoharu Tokutomi2, Kayono Yamamoto4, Kinuko Ohneda5, Shigeo Kure3, Yoko Aoki6, Hideki Katagiri7, Yasushi Ishigaki2, Shojiro Sawada7, Makoto Sasaki2, Masayuki Yamamoto8.   

Abstract

Certain large genome cohort studies attempt to return the individual genomic results to the participants; however, the implementation process and psychosocial impacts remain largely unknown. The Tohoku Medical Megabank Project has conducted large genome cohort studies of general residents. To implement the disclosure of individual genomic results, we extracted the potential challenges and obstacles. Major challenges include the determination of genes/disorders based on the current medical system in Japan, the storage of results, prevention of misunderstanding, and collaboration of medical professionals. To overcome these challenges, we plan to conduct multilayer pilot studies, which deal with different disorders/genes. We finally chose familial hypercholesterolemia (FH) as a target disease for the first pilot study. Of the 665 eligible candidates, 33.5% were interested in the pilot study and provided consent after an educational "genetics workshop" on the basic genetics and medical facts of FH. The genetics professionals disclosed the results to the participants. All positive participants were referred to medical care, and a serial questionnaire revealed no significant psychosocial distress after the disclosure. Return of genomic results to research participants was implemented using a well-prepared protocol. To further elucidate the impact of different disorders, we will perform multilayer pilot studies with different disorders, including actionable pharmacogenomics and hereditary tumor syndromes.
© 2021. The Author(s), under exclusive licence to The Japan Society of Human Genetics.

Entities:  

Mesh:

Year:  2021        PMID: 34234266     DOI: 10.1038/s10038-021-00952-8

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  42 in total

1.  Medicine. Whole-genome sequencing: the new standard of care?

Authors:  Liam R Brunham; Michael R Hayden
Journal:  Science       Date:  2012-06-01       Impact factor: 47.728

Review 2.  Genomic medicine--an updated primer.

Authors:  W Gregory Feero; Alan E Guttmacher; Francis S Collins
Journal:  N Engl J Med       Date:  2010-05-27       Impact factor: 91.245

Review 3.  Return of genetic testing results in the era of whole-genome sequencing.

Authors:  Bartha Maria Knoppers; Ma'n H Zawati; Karine Sénécal
Journal:  Nat Rev Genet       Date:  2015-08-04       Impact factor: 53.242

Review 4.  Return of individual research results and incidental findings: facing the challenges of translational science.

Authors:  Susan M Wolf
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-07-15       Impact factor: 8.929

Review 5.  Diagnostic clinical genome and exome sequencing.

Authors:  Leslie G Biesecker; Robert C Green
Journal:  N Engl J Med       Date:  2014-06-19       Impact factor: 91.245

6.  Return of genomic results to research participants: the floor, the ceiling, and the choices in between.

Authors:  Gail P Jarvik; Laura M Amendola; Jonathan S Berg; Kyle Brothers; Ellen W Clayton; Wendy Chung; Barbara J Evans; James P Evans; Stephanie M Fullerton; Carlos J Gallego; Nanibaa' A Garrison; Stacy W Gray; Ingrid A Holm; Iftikhar J Kullo; Lisa Soleymani Lehmann; Cathy McCarty; Cynthia A Prows; Heidi L Rehm; Richard R Sharp; Joseph Salama; Saskia Sanderson; Sara L Van Driest; Marc S Williams; Susan M Wolf; Wendy A Wolf; Wylie Burke
Journal:  Am J Hum Genet       Date:  2014-05-08       Impact factor: 11.025

7.  Managing incidental findings and research results in genomic research involving biobanks and archived data sets.

Authors:  Susan M Wolf; Brittney N Crock; Brian Van Ness; Frances Lawrenz; Jeffrey P Kahn; Laura M Beskow; Mildred K Cho; Michael F Christman; Robert C Green; Ralph Hall; Judy Illes; Moira Keane; Bartha M Knoppers; Barbara A Koenig; Isaac S Kohane; Bonnie Leroy; Karen J Maschke; William McGeveran; Pilar Ossorio; Lisa S Parker; Gloria M Petersen; Henry S Richardson; Joan A Scott; Sharon F Terry; Benjamin S Wilfond; Wendy A Wolf
Journal:  Genet Med       Date:  2012-04       Impact factor: 8.822

8.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.

Authors:  Sarah S Kalia; Kathy Adelman; Sherri J Bale; Wendy K Chung; Christine Eng; James P Evans; Gail E Herman; Sophia B Hufnagel; Teri E Klein; Bruce R Korf; Kent D McKelvey; Kelly E Ormond; C Sue Richards; Christopher N Vlangos; Michael Watson; Christa L Martin; David T Miller
Journal:  Genet Med       Date:  2016-11-17       Impact factor: 8.822

9.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Authors:  Robert C Green; Jonathan S Berg; Wayne W Grody; Sarah S Kalia; Bruce R Korf; Christa L Martin; Amy L McGuire; Robert L Nussbaum; Julianne M O'Daniel; Kelly E Ormond; Heidi L Rehm; Michael S Watson; Marc S Williams; Leslie G Biesecker
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822

10.  Clinical application of exome sequencing in undiagnosed genetic conditions.

Authors:  Anna C Need; Vandana Shashi; Yuki Hitomi; Kelly Schoch; Kevin V Shianna; Marie T McDonald; Miriam H Meisler; David B Goldstein
Journal:  J Med Genet       Date:  2012-05-11       Impact factor: 6.318

View more
  3 in total

1.  Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants.

Authors:  Kinuko Ohneda; Yohei Hamanaka; Hiroshi Kawame; Nobuo Fuse; Fuji Nagami; Yoichi Suzuki; Yumi Yamaguchi-Kabata; Muneaki Shimada; Atsushi Masamune; Yoko Aoki; Takanori Ishida; Masayuki Yamamoto
Journal:  Breast Cancer       Date:  2022-09-26       Impact factor: 3.307

2.  A Pilot Study for Return of Individual Pharmacogenomic Results to Population-Based Cohort Study Participants.

Authors:  Kinuko Ohneda; Masahiro Hiratsuka; Hiroshi Kawame; Fuji Nagami; Yoichi Suzuki; Kichiya Suzuki; Akira Uruno; Mika Sakurai-Yageta; Yohei Hamanaka; Makiko Taira; Soichi Ogishima; Shinichi Kuriyama; Atsushi Hozawa; Hiroaki Tomita; Naoko Minegishi; Junichi Sugawara; Inaho Danjoh; Tomohiro Nakamura; Tomoko Kobayashi; Yumi Yamaguchi-Kabata; Shu Tadaka; Taku Obara; Eiji Hishimuma; Nariyasu Mano; Masaki Matsuura; Yuji Sato; Masateru Nakasone; Yohei Honkura; Jun Suzuki; Yukio Katori; Yoichi Kakuta; Atsushi Masamune; Yoko Aoki; Masaharu Nakayama; Shigeo Kure; Kengo Kinoshita; Nobuo Fuse; Masayuki Yamamoto
Journal:  JMA J       Date:  2022-03-11

Review 3.  Applying implementation science to improve care for familial hypercholesterolemia.

Authors:  Laney K Jones; Ross C Brownson; Marc S Williams
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-04-01       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.